April 27, 2022
Webinar
Finnegan
Subject matter eligibility under 35 U.S.C. § 101 impacts many different industries, and guidance provided by the U.S. Patent and Trademark Office (USPTO) and courts is continuing to evolve. Our panelists will provide an overview of the most recent developments in the application of § 101 to a variety of technologies, including digital health, medical devices, diagnostics, automotive, robotics, life sciences, and natural products. We will discuss concerns relevant to protecting your company’s products/services and offer practical suggestions for overcoming potential § 101 challenges, or avoiding them altogether.
We will discuss the following topics:
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Webinar
Building a Strong ADC Patent Portfolio – From Prosecution and Litigation Perspectives
May 15, 2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.